China "prepares" for H5N1 sample sharing

29 April 2007

The Chinese government is reported to be "preparing" to share samples of avian influenza that were contracted by humans, according to a report in the International Herald Tribune. Recently, the World Health Organization reported that it had not received any samples from the country in over a year.

China escaped criticism for refusing to share samples of avian influenza found in humans with the World Health Organization, at a time when Indonesia was refusing to collaborate with the international agency, in a dispute over the intellectual property rights of discoveries made from Indonesian-supplied data (Marketletters passim). Despite China's reluctance to work with the WHO, Indonesia's stance was described as "unprecedented."

The China Daily newspaper, meanwhile, reported that the Health Ministry was in the process of arranging the delivery of H5N1 samples to the WHO. The government-controlled newspaper claimed that the Ministry "will send two recent samples of the virus and one from a Beijing resident who was infected in 2003."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight